{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:41:27Z","timestamp":1786765287678,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:00:00Z","timestamp":1673654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"NIAAA","doi-asserted-by":"publisher","award":["U24AA026969"],"award-info":[{"award-number":["U24AA026969"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.conctc.2023.101074","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T12:08:34Z","timestamp":1674043714000},"page":"101074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4236-9135","authenticated-orcid":false,"given":"Wanzhu","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-4909","authenticated-orcid":false,"given":"Samer","family":"Gawrieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1774-0104","authenticated-orcid":false,"given":"Srinivasan","family":"Dasarathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9018-7988","authenticated-orcid":false,"given":"Mack C.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Simonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-382X","authenticated-orcid":false,"given":"Kavish R.","family":"Patidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0836-2527","authenticated-orcid":false,"given":"Gyongyi","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Radaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-573X","authenticated-orcid":false,"given":"Vijay","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.conctc.2023.101074_bib1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J. Hepatol."},{"issue":"26","key":"10.1016\/j.conctc.2023.101074_bib2","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.conctc.2023.101074_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/MCG.0b013e3181fdef1d","article-title":"Clinical characteristics and mortality of hospitalized alcoholic hepatitis patients in the United States","volume":"45","author":"Liangpunsakul","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.conctc.2023.101074_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.alcohol.2018.02.003","article-title":"Mortality and costs associated with alcoholic hepatitis: a claims analysis of a commercially insured population","volume":"71","author":"Thompson","year":"2018","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.conctc.2023.101074_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ajg.2009.593","article-title":"Alcoholic liver disease","volume":"105","author":"O'Shea","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"EASL clinical practical guidelines: management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","article-title":"ACG clinical guideline: alcoholic liver disease","volume":"113","author":"Singal","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.conctc.2023.101074_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.gtc.2011.06.008","article-title":"Alcoholic hepatitis: prognostic models and treatment","volume":"40","author":"Singal","year":"2011","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"17","key":"10.1016\/j.conctc.2023.101074_bib9","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.conctc.2023.101074_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1053\/j.gastro.2016.12.019","article-title":"In patients with severe alcoholic hepatitis, prednisolone increases susceptibility to infection and infection-related mortality, and is associated with high circulating levels of bacterial DNA","volume":"152","author":"Vergis","year":"2017","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or Placebo\u2014a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.conctc.2023.101074_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/9781119436812.ch53","article-title":"Alcoholic liver disease","author":"Gao","year":"2020","journal-title":"Liver: Biology and Pathobiology"},{"issue":"3","key":"10.1016\/j.conctc.2023.101074_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/hep.28456","article-title":"Interleukin\u20101 and inflammasomes in alcoholic liver disease\/acute alcoholic hepatitis and nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"64","author":"Tilg","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2018.10.023","article-title":"Inflammatory pathways in alcoholic steatohepatitis","volume":"70","author":"Gao","year":"2019","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.conctc.2023.101074_bib15","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1172\/JCI60777","article-title":"IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice","volume":"122","author":"Petrasek","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.conctc.2023.101074_bib16","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/liv.13430","article-title":"Interleukin\u20101 inhibition facilitates recovery from liver injury and promotes regeneration of hepatocytes in alcoholic hepatitis in mice","volume":"37","author":"Iracheta-Vellve","year":"2017","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.conctc.2023.101074_bib17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.32478","article-title":"IL\u20101 receptor antagonist plus pentoxifylline and zinc for severe alcohol\u2010associated hepatitis","volume":"76","author":"Szabo","year":"2022","journal-title":"Hepatology"},{"issue":"13","key":"10.1016\/j.conctc.2023.101074_bib18","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial","volume":"15","author":"De","year":"2009","journal-title":"World J. Gastroenterol.: WJG"},{"key":"10.1016\/j.conctc.2023.101074_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100549","article-title":"Zinc supplementation and its benefits in the management of chronic liver disease: an in-depth literature review","volume":"25","author":"Bloom","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"4","key":"10.1016\/j.conctc.2023.101074_bib20","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.conctc.2023.101074_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/jlts.2001.25879","article-title":"MELD and PELD: application of survival models to liver allocation","volume":"7","author":"Wiesner","year":"2001","journal-title":"Liver Transplant."},{"issue":"4","key":"10.1016\/j.conctc.2023.101074_bib23","doi-asserted-by":"crossref","first-page":"G516","DOI":"10.1152\/ajpgi.00537.2010","article-title":"Innate immunity in alcoholic liver disease","volume":"300","author":"Gao","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.conctc.2023.101074_bib24","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/0884533611433534","article-title":"Zinc and liver disease","volume":"27","author":"Mohammad","year":"2012","journal-title":"Nutr. Clin. Pract."},{"issue":"4","key":"10.1016\/j.conctc.2023.101074_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.livres.2017.12.004","article-title":"Targeting the gut barrier for the treatment of alcoholic liver disease","volume":"1","author":"Zhou","year":"2017","journal-title":"Liver research"},{"issue":"6","key":"10.1016\/j.conctc.2023.101074_bib26","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0002-9440(10)62478-9","article-title":"Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress","volume":"166","author":"Zhou","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.conctc.2023.101074_bib27","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.conctc.2023.101074_bib28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmi.2016.11.003","article-title":"Validation of the new Sepsis-3 definitions: proposal for improvement in early risk identification","volume":"23","author":"Giamarellos-Bourboulis","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.conctc.2023.101074_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2307\/2531910","article-title":"Sample sizes based on the log-rank statistic in complex clinical trials","volume":"44","author":"Lakatos","year":"1988","journal-title":"Biometrics"},{"issue":"4","key":"10.1016\/j.conctc.2023.101074_bib31","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: a systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.conctc.2023.101074_bib32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.conctc.2023.101074_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MEG.0b013e3283435d76","article-title":"Prevention of hepatorenal syndrome in patients with cirrhosis and ascites: a pilot randomized control trial between pentoxifylline and placebo","volume":"23","author":"Tyagi","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.conctc.2023.101074_bib34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/j.gastro.2015.04.044","article-title":"Combining data from liver disease scoring systems better predicts outcomes of patients with alcoholic hepatitis","volume":"149","author":"Louvet","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.conctc.2023.101074_bib36","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids","volume":"48","author":"Louvet","year":"2008","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.conctc.2023.101074_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.conctc.2023.101074_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2050-6511-14-40","article-title":"Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes","volume":"14","author":"Urien","year":"2013","journal-title":"BMC Pharmacology and Toxicology"},{"issue":"3","key":"10.1016\/j.conctc.2023.101074_bib39","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/00063030-200519030-00005","volume":"19","author":"Waugh","year":"2005","journal-title":"Anakinra, BioDrugs"},{"issue":"1","key":"10.1016\/j.conctc.2023.101074_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0009-9236(03)00094-8","article-title":"Pharmacokinetics of anakinra in subjects with different levels of renal function","volume":"74","author":"Yang","year":"2003","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423000200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865423000200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:09:06Z","timestamp":1762520946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865423000200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":40,"alternative-id":["S2451865423000200"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101074","relation":{},"ISSN":["2451-8654"],"issn-type":[{"value":"2451-8654","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design of a multicenter randomized clinical trial for treatment of Alcohol-Associated Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2023.101074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101074"}}